Aurobindo Pharma to acquire 26 percent stake in solar energy company
Telangana: Aurobindo Pharma has announced that the Company will be investing Rs.10.40 crores to acquire 26 percent equity and other securities of Swarnaaskshu Solar Power Private Limited, a company under incorporation.
The Board of Directors of Aurobindo has approved to enter into a power purchase agreement with Swarnaaskshu Solar Power Private Limited for purchase of solar power under the captive power policy of the Government of Telangana.
Swarnaaskshu is under incorporation by the relatives of K. Nithyananda Reddy, promoter and Vice Chairman & Managing Director of the Company.
Swarnaaskshu will be setting up of a Solar powerplant with the capacity of 30MW AC (40MW DC) in the state of Telangana.
Read also: Aurobindo Pharma arm gets positive opinion for biosimilar Dyrupeg from EMA
Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.
The company has 29 manufacturing and packaging facilities that are approved by regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The Company’s product portfolio is spread over seven major therapeutic/product areas encompassing CNS, Anti-Retroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.
Read also: Aurobindo Pharma arm CuraTeQ Biologics gets UK MHRA nod for cancer treatment Bevqolva
